
Carolyn L. Smith
Examiner (ID: 10258)
| Most Active Art Unit | 1631 |
| Art Unit(s) | 1631 |
| Total Applications | 423 |
| Issued Applications | 101 |
| Pending Applications | 54 |
| Abandoned Applications | 268 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14596699
[patent_doc_number] => 10351531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Pyrazole derivatives as modulators of the 5-HT
[patent_app_type] => utility
[patent_app_number] => 15/657896
[patent_app_country] => US
[patent_app_date] => 2017-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 32882
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15657896
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/657896 | Pyrazole derivatives as modulators of the 5-HT | Jul 23, 2017 | Issued |
Array
(
[id] => 12151468
[patent_doc_number] => 20180022732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET'
[patent_app_type] => utility
[patent_app_number] => 15/657057
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39284
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15657057
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/657057 | Compounds useful for treating disorders related to RET | Jul 20, 2017 | Issued |
Array
(
[id] => 12023588
[patent_doc_number] => 20170313687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'Compounds and Compositions for Cognition-Enhancement, Methods of Making, and Methods of Treating'
[patent_app_type] => utility
[patent_app_number] => 15/653453
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 50743
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15653453
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/653453 | Compounds and Compositions for Cognition-Enhancement, Methods of Making, and Methods of Treating | Jul 17, 2017 | Abandoned |
Array
(
[id] => 12154945
[patent_doc_number] => 20180026210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES'
[patent_app_type] => utility
[patent_app_number] => 15/652298
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16855
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652298
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/652298 | Organic electroluminescent materials and devices | Jul 17, 2017 | Issued |
Array
(
[id] => 16169440
[patent_doc_number] => 10710988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Piperazine derivative
[patent_app_type] => utility
[patent_app_number] => 16/314730
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18494
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314730
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314730 | Piperazine derivative | Jul 17, 2017 | Issued |
Array
(
[id] => 17323568
[patent_doc_number] => 11214562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Cyclohexyl benzamide compounds
[patent_app_type] => utility
[patent_app_number] => 16/316167
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6210
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316167 | Cyclohexyl benzamide compounds | Jul 16, 2017 | Issued |
Array
(
[id] => 16012501
[patent_doc_number] => 20200181093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => Pyrimidinone Derivatives and Uses Thereof to Neutralize the Biological Activity of Chemokines
[patent_app_type] => utility
[patent_app_number] => 16/316614
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316614
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316614 | Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines | Jul 12, 2017 | Issued |
Array
(
[id] => 14243695
[patent_doc_number] => 10272030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Amino-pyrimidine skeletal muscle modulators
[patent_app_type] => utility
[patent_app_number] => 15/645977
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29444
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645977
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645977 | Amino-pyrimidine skeletal muscle modulators | Jul 9, 2017 | Issued |
Array
(
[id] => 14371081
[patent_doc_number] => 20190159453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => HERBICIDAL PYRIMIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/320701
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320701 | Herbicidal pyrimidine compounds | Jul 9, 2017 | Issued |
Array
(
[id] => 14371081
[patent_doc_number] => 20190159453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => HERBICIDAL PYRIMIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/320701
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320701 | Herbicidal pyrimidine compounds | Jul 9, 2017 | Issued |
Array
(
[id] => 14929745
[patent_doc_number] => 20190300510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => LACTAM, CYCLIC UREA AND CARBAMATE, AND TRIAZOLONE DERIVATIVES AS POTENT AND SELECTIVE ROCK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/315674
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315674
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315674 | Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors | Jul 5, 2017 | Issued |
Array
(
[id] => 17267478
[patent_doc_number] => 11192889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Tetrahydronaphthyridinepentanamide integrin antagonists
[patent_app_type] => utility
[patent_app_number] => 16/315093
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12996
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315093 | Tetrahydronaphthyridinepentanamide integrin antagonists | Jul 4, 2017 | Issued |
Array
(
[id] => 14341909
[patent_doc_number] => 20190152927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => NOVEL PROCESS FOR THE PREPARATION OF 2-{4-[(5,6-DIPHENYL PYRAZIN-2-YL)(ISOPROPYL)AMINO]BUTOXY}-N-(METHYLSULFONYL)ACETAMIDE AND NOVEL POLYMORPHS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315671
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315671
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315671 | Process for the preparation of 2-{4-[(5,6-diphenyl pyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide and novel polymorphs thereof | Jun 29, 2017 | Issued |
Array
(
[id] => 12769699
[patent_doc_number] => 20180148401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => Compounds and Methods of Use Thereof for Treating Tumors
[patent_app_type] => utility
[patent_app_number] => 15/638991
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15638991
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/638991 | Compounds and methods of use thereof for treating tumors | Jun 29, 2017 | Issued |
Array
(
[id] => 16704312
[patent_doc_number] => 10954232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Pyrazole derivative as ALK5 inhibitor and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/313948
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20649
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313948 | Pyrazole derivative as ALK5 inhibitor and uses thereof | Jun 29, 2017 | Issued |
Array
(
[id] => 13076991
[patent_doc_number] => 10058550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Methods of treating heart failure
[patent_app_type] => utility
[patent_app_number] => 15/629567
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 181350
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15629567
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/629567 | Methods of treating heart failure | Jun 20, 2017 | Issued |
Array
(
[id] => 14341911
[patent_doc_number] => 20190152928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => PROCESS FOR MELAMINE PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/318736
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318736
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318736 | Process for melamine purification | Jun 20, 2017 | Issued |
Array
(
[id] => 12099145
[patent_doc_number] => 09856232
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-01-02
[patent_title] => 'Dihydropyrimidinone derivatives'
[patent_app_type] => utility
[patent_app_number] => 15/628476
[patent_app_country] => US
[patent_app_date] => 2017-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 20
[patent_no_of_words] => 11328
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15628476
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/628476 | Dihydropyrimidinone derivatives | Jun 19, 2017 | Issued |
Array
(
[id] => 14566795
[patent_doc_number] => 20190211004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => PROCESS FOR PRODUCING LAMIVUDINE AND EMTRICITABINE
[patent_app_type] => utility
[patent_app_number] => 16/301255
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301255
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301255 | Process for producing Lamivudine and Emtricitabine | Jun 12, 2017 | Issued |
Array
(
[id] => 14500939
[patent_doc_number] => 20190194124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/307702
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307702 | Compositions and methods for treating cancer | May 25, 2017 | Issued |